Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (MCK)
NYSE:MCK
Holding MCK?
Track your performance easily
MCK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$431.35 - $637.51
Previous Close$623.19
Volume512.79K
Average Volume (3M)1.01M
Market Cap
$79.11B
Enterprise Value$84.19B
Total Cash (Recent Filing)$2.51B
Total Debt (Recent Filing)$7.22B
Price to Earnings (P/E)32.3
Beta0.49
Next Earnings
Jan 29, 2025EPS Estimate
$8.45Next Dividend Ex-Date
Dec 02, 2024Dividend Yield0.41%
Share Statistics
EPS (TTM)19.29
Shares Outstanding126,940,097
10 Day Avg. Volume1,007,779
30 Day Avg. Volume1,007,585
Standard Deviation0.06
R-Squared0.13
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-26.13
Price to Sales (P/S)0.24
Price to Cash Flow (P/CF)9.30
P/FCF Ratio10.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.25
Enterprise Value/Gross Profit6.56
Enterprise Value/Ebitda19.04
Forecast
1Y Price Target
$646.86Price Target Upside3.80% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering15
McKesson News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMCK posted an adjusted EPS beat, significantly higher than consensus estimates, indicating strong financial performance.
Oncology GrowthThe oncology segment is a strategic pillar for McKesson, with significant investments and acquisitions expected to contribute substantially to revenue and growth.
Shareholder ConfidenceA $400mm increase to the share repurchase program was announced, indicating confidence in the company's financial health.
Bears Say
Earnings GuidanceThe company further reducing F2025 EPS guidance and second, the need to reduce its longer-term EPS guidance.
Operational PerformanceMcKesson missed FY4Q24 operationally on multiple fronts, then followed up with an even worse FY1Q25 that included negative revenue and AOI variances in US Pharma, Med-Surg, and Prescription Tech, with several negative operating guidance adjustments.
Revenue GuidanceThe company reduced its revenue guidance in its Med-Surg business, pointing to normalization of market conditions and lower volumes.
---
Ownership Overview
0.08% Insiders
23.07% Mutual Funds
17.78% Other Institutional Investors
38.83% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MCK FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest stock price was $431.35 and its highest was $637.51 in the past 12 months.
What is Mckesson Corp.’s market cap?
Currently, no data Available
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is Jan 29, 2025 which is in 66 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Nov 06, 2024. The company reported $7.07 earnings per share for the quarter, beating the consensus estimate of $6.881 by $0.189.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $0.71 which represents an annual dividend yield of 0.41%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is $8.45.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 126,940,094 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $7.07 in its last earnings report, beating expectations of $6.881. Following the earnings report the stock price went up 10.595%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Among the largest hedge funds holding Mckesson Corp.’s share is Brandes Investment Partners LP. It holds Mckesson Corp.’s shares valued at 186M.
---
McKesson Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$646.86 (3.80% Upside)
$646.86 (3.80% Upside)
Blogger Sentiment
Bullish
MCK Sentiment 90%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 824.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 2.6%
Last 30 Days ▼ 2.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
36.90%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
9.59%
Trailing 12-Months
Company Description
Mckesson Corp.
Incorporated in 1833, Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools. The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions.
---
MCK Company Deck
---
MCK Earnings Call
Q2 2024
0:00 / 0:00
---
MCK Revenue Breakdown
90.22% U.S. Pharmaceutical
4.57% International
3.66% Medical-Surgical Solutions
1.54% Prescription Technology Solutions
---
MCK Stock 12 Month Forecast
Average Price Target
$646.86
▲(3.80% Upside)
Technical Analysis
Best Analysts Covering MCK
1 Year
1 Year Success Rate
20/21 ratings generated profit
1 Year Average Return
+31.59%
reiterated a buy rating 18 days ago
Copying Michael Cherny's trades and holding each position for 1 Year would result in 95.24% of your transactions generating a profit, with an average return of +31.59% per trade.
---